EU-Wide Compulsory Licensing Plan Draws R&D Industry Ire

The European Commission says its proposals on EU-level compulsory licensing and a unitary supplementary protection certificate will create a more efficient and future-proof framework for intellectual property rights.

PS1807_Pills Under Scrutiny_141058420_1200.jpg
The EU is focusing on IP issues relating to medicines • Source: Shutterstock

Just a day after introducing its plans for overhauling the EU pharmaceutical legislation, the European Commission has launched another set of major proposals, this time including a new EU-level system for issuing compulsory licences for crisis-related products such as medicines.

The "patent package" comprises four draft regulations that the commission says will complement Europe’s new unitary patent regime, which is...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography